XTP-NAD+500-004 — XTP NAD+
Vendor COAXTP | NAD+, last activity 3 months ago
3 related batch concerns · 1 mention
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
The label says 500 mg. Janoshik weighed 491.4 mg — 2% less than the label. Your dose depends on what is really in the vial, so the steps below use the measured amount.
Draw
20 units
on a U-100 insulin syringe, for 50 mg
Going by the label you would draw 20 units — which from this vial is actually 49.1 mg, not 50 mg.
- The vial holds dry powder: 491.4 mg of NAD+, as weighed.
- Water spreads that powder evenly through the liquid: 491.4 mg ÷ 2 ml = 245.7 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 2.46 mg.
- Your dose divided by that: 50 mg ÷ 2.46 mg = 20 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
3 of 5 tested
also XTP
Retatrutide, same vendor
An independent test identified a different peptide—Tirzepatide instead of Retatrutide—contradicting the vendor's own…
JEEP
Vendor certificate from Janoshik reports 595.85 mg
also XTP
Retatrutide, same vendor
XTP rarely publishes certificates for its retatrutide batches, making this one of the few with independent sterility…
Community Intelligence
- 4 concern reports involving XTP-R30-003
- 1 concern report involving JP20260011
- 1 concern report involving SJ26-4-01
Reported against other XTP NAD+ batches, not this one.
Activity
[https://janoshik.com/tests/197428-NAD500_E22E7XB2ZMB1](https://janoshik.com/tests/197428-NAD500_E22E7XB2ZMB1)
View in Telegram →members onlyVendor
XTP